NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The firm offers products like Quilience, which is a clinical-stage pharmaceutical compound. The company aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The firm also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The firm is a publicly traded company, listing on the NASDAQ.
Based on 6 analysts giving stock ratings to NCEL, updated on Apr 01, 2025
Sell
Strong buy
0
Buy
0
Hold
3
Sell
1
Strong sell
2
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for NCEL. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: NCEL is a Sell candidate.
NCEL stock price ended at $2.35 on Wednesday, after rising 10.85%
On the latest trading day Apr 01, 2026, the stock price of NCEL rose by 10.85%, climbing from $2.31 to $2.35. Throughout the session, the stock experienced a volatility of 9.78%, with prices fluctuating between a daily low of $2.25 and a high of $2.47. Alongside this price increase, trading volume also rose by 8.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 32.0K shares were traded, amounting to a market value of approximately $10.7M.
NCEL Technical Signals
Technical Signals Summary
Buy Signals 1
Neutral Signals 2
Sell Signals 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
NCEL currently exhibits 1 buy signals and 4 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 25% during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for NCEL
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for NCEL. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to NCEL?
According to technical analysis, NewcelX AG has an aggregate signal of Sell. NewcelX AG has 1 Buy signals, 2 Neutral Signals and 4 sell signals.
What are the Fibonacci retracement levels for NCEL?
The Fibonacci retracement level for NewcelX AG is between 0% and 23.6%
What is the RSI for NewcelX AG?
The RSI for NewcelX AG is currently 48.32, indicating a neutral condition
What is NewcelX AG price for the next 12 months?
NewcelX AG NCEL price for the next 12 months is estimated at $0.
How high is NewcelX AG expected to go?
According to wall street analysts, NewcelX AG is expected to reach a high forecast of $0.